Detalhe da pesquisa
1.
Association of certification, improved quality and better oncological outcomes for rectal cancer in a specialized colorectal unit.
Int J Colorectal Dis
; 36(3): 517-533, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33165684
2.
Mammalian-target of rapamycin inhibition with temsirolimus in myelodysplastic syndromes (MDS) patients is associated with considerable toxicity: results of the temsirolimus pilot trial by the German MDS Study Group (D-MDS).
Br J Haematol
; 175(5): 917-924, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27714772
3.
The histone demethylase UTX regulates stem cell migration and hematopoiesis.
Blood
; 121(13): 2462-73, 2013 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-23365460
4.
Loss of prolyl hydroxylase-2 in myeloid cells and T-lymphocytes impairs tumor development.
Int J Cancer
; 134(4): 849-58, 2014 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23913502
5.
Significant decrease of the pathological stage I rectal carcinoma in the era of neoadjuvant therapy-A matter of concern.
Eur J Cancer
; 159: 275-282, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34800758
6.
Intimal pulmonary artery sarcoma presenting as severe dyspnea and right heart insufficiency.
Onkologie
; 33(6): 313-6, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20523095
7.
Predictive value of Ki67 and p53 in locally advanced rectal cancer: correlation with thymidylate synthase and histopathological tumor regression after neoadjuvant 5-FU-based chemoradiotherapy.
World J Gastroenterol
; 14(7): 1060-6, 2008 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-18286688
8.
Prognostic value of histologic tumor regression, thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer UICC Stage II/III after neoadjuvant chemoradiotherapy.
Am J Surg Pathol
; 30(9): 1169-74, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16931962
9.
Immunohistochemical analysis of thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer (cUICC II/III): correlation with histopathologic tumor regression after 5-fluorouracil-based long-term neoadjuvant chemoradiotherapy.
Am J Surg Pathol
; 29(10): 1304-9, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16160472
10.
Lymphangiogenesis in regional lymph nodes is an independent prognostic marker in rectal cancer patients after neoadjuvant treatment.
PLoS One
; 6(11): e27402, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22087309
11.
Thymidylate synthase genotypes and tumour regression in stage II/III rectal cancer patients after neoadjuvant fluorouracil-based chemoradiation.
Cancer Lett
; 272(2): 221-5, 2008 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-18722050
12.
Eltrombopag fails to improve severe thrombocytopenia in late-stage dyskeratosis congenita and diamond-blackfan-anaemia.
Thromb Haemost
; 108(2): 397-8, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22739569
13.
Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
J Clin Oncol
; 24(25): 4062-8, 2006 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16943523
14.
Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer.
J Pathol
; 204(5): 562-8, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15538739